News & Analysis on Clinical Trial Services & Contract Research And Development
Bioalliance Pharma, a pharmaceutical company focused on the field of drug resistance, revealed results of a study that indicated a new formulation of miconazole administered as a bioadhesive extended release buccal tablet was more effective...
Researchers have identified a protein that protects the brain from the destructive effects of Alzheimer's disease, protecting brain cells by blocking another toxic protein that contributes to the disease process
A report focusing on the pharmaceutical and biotechnology markets in Europe has singled out high throughput screening (HTS) as an approach that will provide mechanistic insights and new drug leads with improved efficiency whilst reducing cost.
UK-based packaging giant Rexam has launched a new child-resistant closure designed specifically for use in the pharmaceutical and healthcare markets.
Loma Systems unveil a new entry-level X-ray inspection unit suited for smaller products at a price that allows packagers to enter the market, with the technology available at a 50 per cent price reduction over traditional X-ray units.
A novel computational method to detect disease-causing genes accurately and rapidly has been reported in the latest issue of Science (22 October).
Sun Chemical has increased the price of all packaging inks and coatings by three to seven per cent this month, blaming rising petrochemical costs that could affect the entire packaging industry for the next couple of years.
US company Sontra Medical has successfully completed the first tests of a novel technology that allows vaccines to be applied topically to the skin, rather than delivered through a needle. Preliminary data suggest the method is as effective as...
Cardinal Health reported its long-delayed fourth-quarter financial results yesterday, revealing a hike in profit and revenues for the three months to end June, but lowered guidance for the first half of this fiscal year.
Germany's MWG Biotech has said it will slash nearly two thirds of its workforce in a further effort to reduce costs, prompting speculation about the long-term future of the company in its present state.
More than half of pharmaceuticals outsourced at least 20 per cent of their ADMET (absorption, distribution, metabolism, excretion and toxicology) studies in 2003, according to a new market research report looking at outsourcing in the sector.